Novartis drug Galvus® approved in EU for monotherapy use in patients with type 2 diabetes unable to take metformin
The European Commission has approved the use of Galvus® (vildagliptin)...
6 February 2012 | By Chamberlain Healthcare PR
The European Commission has approved the use of Galvus® (vildagliptin)...